SABS compared with IRD: revenue, margins and what each company keeps, and the suppliers and customers both name

SABSSAB Biotherapeutics, Inc.

Mkt capRevenueRevenue

IRDOpus Genetics, Inc.

Mkt capRevenueRevenue

Compare

SABSSAB Biotherapeutics, Inc.

IRDOpus Genetics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

SABSwithIRD

No shared trading history for SABS and IRD.

Shared co-movers: not yet measured (SABS, IRD).

SABS, solidIRD, hatchedr = correlationBar = r to r 0.75Source: daily closes

SABSSAB Biotherapeutics, Inc.

3.31▼−1.34%· post 3.31· delayed

Mkt cap$304.8MRevenue$114,698Q4 FY24Revenue—

IRDOpus Genetics, Inc.

3.72▲+1.23%· post 3.72· delayed

After hoursNov 2 '26delayed

Mkt cap$305.3MRevenue$755,000Q2 FY26Revenue$14MFY25

Compare

After hoursNov 2 '26delayed

SABSSAB Biotherapeutics, Inc.

IRDOpus Genetics, Inc.

3.31▼−1.34%post 3.31delayed

Price

3.72▲+1.23%post 3.72delayed

$304.8M

Mkt cap

$305.3M

Q4 FY24$114,698

Revenue

$755,000Q2 FY26

—

Revenue

$14MFY25

SABS3.31▼−1.34%vsIRD3.72▲+1.23%After hoursNov 2 '26delayed